Literature DB >> 9504678

Neoplasms with neural differentiation: a review. Part II: Malignant neoplasms.

O P Sangüeza1, L Requena.   

Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) encompass a wide and unusual group of neoplasms with features of neural differentiation. They most commonly present as spindle cell neoplasms and it can be difficult to differentiate them from other spindle cell neoplasms such as leiomyosarcomas, fibrosarcomas and synovial sarcomas. Strict criteria need to be applied in order to make the diagnosis of MPNSTs. Helpful features include contiguity with a nerve or an association with von Recklinghausen disease. The use of immunohistochemical stains may also help to confirm the diagnosis. Markers such as S-100 protein, neurofilament, epithelial membrane antigen and Leu-7 (CD57) are frequently used to assess neural differentiation in these neoplasms. In addition to the spindle cell pattern, MPNSTs may also display an epithelioid pattern. Rarely, other elements may be seen including glands in the so-called glandular MPNST or muscle in triton tumors. In more unusual cases cartilage, adipose tissue and even bone are present. Also included in the group of MPNSTs are the peripheral neuroepithelial tumor, neurotropic or desmoplastic melanomas and malignant granular cell tumors. MPNSTs are highly aggressive tumors and should be treated accordingly.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504678     DOI: 10.1097/00000372-199802000-00018

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  15 in total

Review 1.  MR imaging of soft tissue tumors and tumor-like lesions.

Authors:  Tal Laor
Journal:  Pediatr Radiol       Date:  2003-12-12

2.  Perineural tumour spread from colon cancer, an unusual cause of trigeminal neuropathy--a case report.

Authors:  Kavitha Nair; Thomas George; Ahmed El Beltagi
Journal:  J Radiol Case Rep       Date:  2015-08-31

3.  Immunophenotyping of Tumours.

Authors:  R Lakhtakia; S K Nema
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma.

Authors:  Jinhyun Kim; Alexander J Lazar; Michael A Davies; Jade Homsi; Nicholas E Papadopoulos; Wen-Jen Hwu; Agop Y Bedikian; Scott E Woodman; Sapna P Patel; Patrick Hwu; Kevin B Kim
Journal:  J Cutan Pathol       Date:  2012-07-19       Impact factor: 1.587

5.  Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma.

Authors:  Mohammad H Soltani; Rita Pichardo; Ziqui Song; Namrata Sangha; Fabian Camacho; Kapaettu Satyamoorthy; Omar P Sangueza; Vijayasaradhi Setaluri
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

6.  Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.

Authors:  D Fang; J Hallman; N Sangha; T E Kute; J A Hammarback; W L White; V Setaluri
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

7.  Desmoplastic melanoma: a diagnostic dilemma.

Authors:  Ashwin K Alva; Rajeshwara K V
Journal:  J Clin Diagn Res       Date:  2013-06-01

8.  Involvement of PACAP/ADNP signaling in the resistance to cell death in malignant peripheral nerve sheath tumor (MPNST) cells.

Authors:  Alessandro Castorina; Salvatore Giunta; Soraya Scuderi; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2012-03-28       Impact factor: 3.444

9.  Perineural spread of malignant melanoma of the head and neck: clinical and imaging features.

Authors:  Patrick C Chang; Nancy J Fischbein; Timothy H McCalmont; Mohammed Kashani-Sabet; Elizabeth M Zettersten; Amon Y Liu; Jane L Weissman
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

10.  Malignant epithelioid cranial nerve sheath tumor: case report of a radiation response.

Authors:  Barbara J Fisher; Kristopher E B Dennis
Journal:  J Neurooncol       Date:  2006-03-24       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.